The Glycogen-Storage Diseases

  • J. Fernandes
  • G. P. A. Smit
Chapter

Abstract

The glycogen-storage diseases (GSDs) are caused by enzyme defects of glycogen degradation. Some enzyme defects are mainly localized in the liver. Hepatomegaly and hypoglycemia are the main abnormalities. Some enzyme defects are localized in the muscles. Muscle cramps during exertion, progressive weakness and other features of myopathy are predominant. Other enzyme defects are generalized, and they present with variable symptoms related to the organs that are most seriously involved. GSDs are denoted either by the deficient enzyme or by a type number that reflects the historical sequence of elucidation. The latter presentation is used in this chapter. The main characteristics of each GSD type are summarized in Table 6.1.

Keywords

Glycogen Storage Glycogen Storage Disease Metabolic Derangement Glycogen Storage Disease Type Enzyme Defect 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in to check access.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Von Gierke E (1929) Hepato-nephro-megalia glykogenika (Glykogenspeicherkrankheit der Leber and Nieren). Beitr Pathol Anat 82: 497–513Google Scholar
  2. 2.
    Corby DC, Putnam CW, Greene HL (1974) Impaired platelet function in glucose-6-phosphatase deficiency. J Pediatr 85: 71–76PubMedCrossRefGoogle Scholar
  3. 3.
    Milla PJ, Atherton DA, Leonard JV, Wolff OH, Lake BD (1978) Disordered intestinal function in glycogen storage disease. J Inherit Metab Dis 1: 155–157PubMedCrossRefGoogle Scholar
  4. 4.
    Rother KI, Schwenk WF (1995) Glucose production in glycogen storage disease I is not associated with increased cycling through hepatic glycogen. Am J Physiol 269: E774–778PubMedGoogle Scholar
  5. 5.
    Fernandes J, Berger R, Smit GPA (1984) Lactate as a cerebral metabolic fuel for glucose-6-phosphatase deficient children. Pediatr Res 18: 335–339PubMedCrossRefGoogle Scholar
  6. 6.
    Alaupovic P, Fernandes J (1985) The serum apolipoprotein profile of patients with glucose-6-phosphatase deficiency. Pediatr Res 19: 380–384PubMedCrossRefGoogle Scholar
  7. 7.
    Fernandes J, Pikaar NA (1972) Ketosis in hepatic glycogenosis. Arch Dis Child 47: 41–46PubMedCrossRefGoogle Scholar
  8. 8.
    Talente GM, Coleman RA, Craig C (1994) Glycogen storage disease in adults. Review. Ann Intern Med 120: 218–226PubMedGoogle Scholar
  9. 9.
    Labrune P, Trioche P, Duvaltier I et al. (1997) Hepatocellular adenomas in glycogen storage disease type I and III: a series of 43 patients and review of the literature. J Pediatr Gastroenterol Nutrit 24: 276–279CrossRefGoogle Scholar
  10. 10.
    Chen Y-T, Coleman RA, Scheinman JI et al. (199o) Amelioration of proximal renal tubular dysfunction in type I glycogen storage disease with dietary therapy. N Engl J Med 323: 590–593Google Scholar
  11. 11.
    Restaino I, Kaplan BS, Stanley C, Baker L (1993) Nephrolithiasis, hypercitraturia, and a distal renal tubular acidification defect in type I glycogen storage disease. J Pediatr 122: 392–396PubMedCrossRefGoogle Scholar
  12. 12.
    Lee PJ, Patel JS, Fewtrill M et al. (1995) Bone mineralisation in type I glycogen storage disease. Eur J Pediatr 154: 483–487PubMedCrossRefGoogle Scholar
  13. 13.
    Kikuchi M, Hasegawa K, Handa I et al. (1991) Chronic pancreatitis in a child with glycogen storage disease type I. Eur J Pediatr 150: 852–853PubMedCrossRefGoogle Scholar
  14. 14.
    Smit GPA (1993) The long-term outcome of patients with glycogen storage disease type Ia. Eur J Pediatr 152: S52–55PubMedCrossRefGoogle Scholar
  15. 15.
    Lee PJ, Celermajer DS, Robinson J et al. (1994) Hyperlipidaemia does not impair vascular endothelial junction in glycogen storage disease type I a. Atherosclerosis 110: 95–100PubMedCrossRefGoogle Scholar
  16. 16.
    Lee PJ, Patel A, Hindmarsch PC et al. (1995) The prevalence of polycystic ovaries in the hepatic glycogen storage diseases: its association with hyperinsulinism. Clin Endocrinol 42: 601–606CrossRefGoogle Scholar
  17. 17.
    Kishani P, Bengun AR, Chen YT (1996) Pulmonary hypertension in glycogen storage disease Type I a. J Inherit Metab Dis 19: 213–216CrossRefGoogle Scholar
  18. 18.
    Goutieres F, Bourgois M, Trioche P et al. (1997) Moyamoya disease in a child with glycogen storage disease type I a. Neuropediatrics 28: 133–134PubMedCrossRefGoogle Scholar
  19. 19.
    Greene HL, Slonim AE, Burr IM, Moran JR (198o) Type I glycogen storage disease: five years of management with nocturnal intragastric feeding. J Pediatr 96 590–595Google Scholar
  20. 20.
    Chen Y-T, Cornblath M, Sidbury JB (1984) Cornstarch therapy in type I glycogen storage disease. N Engl J Med 31o: 171–175CrossRefGoogle Scholar
  21. 21.
    Chen Y-T, Bazzarre CH, Lee MM, Sidbury JB, Coleman RA (1993) Type I glycogen storage disease: nine years of management with cornstarch. Eur J Pediatr 152: S56–59PubMedCrossRefGoogle Scholar
  22. 22.
    Hayde M, Widhalm K (1990) Effects of cornstarch treatment in very young children with type I glycogen storage disease. Eur J Pediatr 149: 630–633PubMedCrossRefGoogle Scholar
  23. 23.
    Fernandes J (1974) The effect of disaccharides on the hyperlactacidaemia of glucose-6-phosphatase-deficient children. Acta Paediatr Scand 63: 695–698PubMedCrossRefGoogle Scholar
  24. 24.
    Fernandes J, Alaupovic P, Wit JM (1989) Gastric drip feeding in patients with glycogen storage disease type I: its effects on growth and plasma lipids and apolipoproteins. Pediatr Res 25: 327–331PubMedCrossRefGoogle Scholar
  25. 25.
    Wolsdorf JI, Crigler JF (1997) Cornstarch regimens for nocturnal treatment of young adults with type I glycogen storage disease. Am J Clin Nutr 65a 507–1511Google Scholar
  26. 26.
    Nuoffer JM, Mullis PE, Wiesmann UN (1997) Treatment with low-dose diasoxide in two growth-retarded prepubertal girsl with glycogen storage disease type I a resulted in catch-up growth. J Inherit Metab Dis 20: 790–798PubMedCrossRefGoogle Scholar
  27. 27.
    Wolsdorf JI, Laffel LM, Crigler JF (1997) Metabolic control and renal dysfunction in type I glycogen storage disease. J Inherit Metab Dis 20: 559–568CrossRefGoogle Scholar
  28. 28.
    Levy E, Thibault L, Turgeon J et al. (1993) Beneficial effects of fish-oil supplements on lipids, lipoproteins, and lipoprotein lipase in patients with glycogen storage disease type I. Am J Clin Nutr 57: 922–929PubMedGoogle Scholar
  29. 29.
    Matern D, Starzl TE, Amaout W et al. (1999) Liver transplantation for glycogen storage diseases types I, III and IV. Eur J Pediatr 158[Suppl. 21: S43–48CrossRefGoogle Scholar
  30. 30.
    Ryan IP, Havel RJ, Laros RK (1994) Three consecutive pregnancies in a patient with glycogen storage disease type I A (von Gierke’s disease). Am J Obstet Gynecol 170: 1687–1691PubMedGoogle Scholar
  31. 31.
    Lei KJ, Shelly LL, Pan CJ, Sidbury JB, Chou JY (1993) Mutations in the glucose-phosphatase gene that cause glycogen storage disease type Ia. Science 262: 580–583PubMedCrossRefGoogle Scholar
  32. 32.
    Veiga-da-Cunha M, Gerin I, van Schaftingen E (woo) How many forms of glycogen storage disease type I? Eur J Pediatr (in press)Google Scholar
  33. 33.
    Simmons PS, Smithson WA, Gronert GA, Haymond MW (1984) Acute myelogenous leukemia and malignant hyper-thermia in a patient with type Ib glycogen storage disease. J Pediatr 105: 428–431PubMedCrossRefGoogle Scholar
  34. 34.
    Kikuchi M, Haginoya K, Miyabayashi S et al. (1990) Secondary amyloidosis in glycogen storage disease type I b. Eur J Pediatr 149: 344–345PubMedCrossRefGoogle Scholar
  35. 35.
    Hoover EG, Du Bois JJ, Samples TL et al. (1996) Treatment of chronic enteritis in glycogen storage disease type 1 B with granulocyte colony-stimulating factor. J Pediatr Gastroenterol Nutr 22: 346–350PubMedCrossRefGoogle Scholar
  36. 36.
    Veiga-da-Cunha M, Gerin I, Chen Y-T et al. (1998) A gene on chromosome 11823 coding for a putative glucose-6-phosphatase translocase is mutated in glycogen storage disease types 1b and Sc. Am J Hum Genet 63: 976–983PubMedCrossRefGoogle Scholar
  37. 37.
    Makos MM, Mc Comb RD, Hart MN, Bennett DR (1987) Alpha-glucosidase deficiency and basilar artery aneurism: report of a sibship. Ann Neurol 22: 629–633PubMedCrossRefGoogle Scholar
  38. 38.
    Kroos MA, van der Kraan M, van Diggelen OP et al. (1995) Glycogen storage disease type II: frequency of three common mutant alleles and their associated clinical phenotypes studied in 121 patients. J Med Genet 32: 836–837PubMedCrossRefGoogle Scholar
  39. 39.
    Mobarhan S, Pintozzi RL, Damle P, Friedman H (1990) Treatment of acid maltase deficiency with a diet high in branched-chain aminoacids. J Parent Enteral Nutr 14: 210–212CrossRefGoogle Scholar
  40. 40.
    Kuo WL, Hirschhorn R, Huie ML, Hirschhorn K (1996) Localisation and ordering of acid alpha-glucosidase (GAA) and thymidine kinase ( TKI) by fluorescence in situ hybridization. Hum Genet 97: 404–406PubMedCrossRefGoogle Scholar
  41. 41.
    Wokke JHJ, Ausems MGEM, van den Boogaard MJH et al. (1995) Genotype-Phenotype correlation in adult-onset acid maltase deficiency. Ann Neurol 38: 450–454PubMedCrossRefGoogle Scholar
  42. 42.
    Hoefsloot LH, van der Ploeg AT, Kroes MA et al. (1990) Adult and infantile glycogenosis type II in one family, explained by allelic diversity. Am J Hum Genet 46: 45–52PubMedGoogle Scholar
  43. 43.
    Haagsma EB, Smit GPA, Niezen-Koning KE et al. (1997) Type III b glycogen storage disease associated with end-stage cirrhosis and hepatocellular carcinoma. Hepatology 25: 537–540PubMedCrossRefGoogle Scholar
  44. 44.
    Coleman RA, Winter HS, Wolf B, Gilchrist JM, Chen Y-T (1992) Glycogen storage disease type III (glycogen debranching enzyme deficiency): correlation of biochemical defects with myopathy and cardiomyopathy. Ann Intern Med 116: 896–900PubMedGoogle Scholar
  45. 45.
    Moses SW, Wandermann KL, Myroz A, Frydman M (1989) Cardiac involvement in glycogen storage disease type III. Eur J Pediatr 148: 764–766PubMedCrossRefGoogle Scholar
  46. 46.
    Cuspidi C, Sampieri L, Peliazoli S et al. (1997) Obstructive hypertrophic cardiomyopathy in Type III glycogen-storage disease. Acta Cardiol 52: 117–123PubMedGoogle Scholar
  47. 47.
    Cohen J, Friedman M (1979) Renal tubular acidosis associated with type III. glycogenosis. Acta Paediatr Scand 68: 779–782PubMedGoogle Scholar
  48. 48.
    Ding JH, de Barsy T, Brown BI et al. (1990) Immunoblot analysis of glycogen debranching enzyme in different subtypes of glycogen storage disease type III. J Pediatr 116: 95–100PubMedCrossRefGoogle Scholar
  49. 49.
    Gremse DA, Bucavalas JC, Balistreri WF (1990) Efficacy of cornstarch therapy in type III glycogen storage disease. Am J Clin Nutr 52: 671–674PubMedGoogle Scholar
  50. 50.
    Slonim AE, Coleman RA, Moses SW (1984) Myopathy and growth failure in debrancher enzyme deficiency: improvement with high-protein nocturnal enteral therapy. J Pediatr 105: 906–911PubMedCrossRefGoogle Scholar
  51. 51.
    De Parscau L, Gibaud P, Hermier M, Francois R (1989) l’Alimentation intragastrique nocturne continue dans les glycogenoses de type I et III. Pediatrie 41: 97–203Google Scholar
  52. 52.
    Shen J, Bao Y, Liu HM et al. (1996) Mutations in exon 3 of the glycogen debranching enzyme gene are assiociated with glycogen storage disease type III that is differentially expressed in liver and muscle. J Clin Invest 98: 352–357PubMedCrossRefGoogle Scholar
  53. 53.
    Mc Conkie-Rosell A, Wilson C, Piccoli DA et al. (1996) Clinical and laboratory findings in four patients with the non-progressive hepatic form of type IV glycogen storage disease. J Inherit Metab Dis 19: 51–58CrossRefGoogle Scholar
  54. 54.
    Bao Y, Kishumi P, Wu JY, Chen YT (1996) Hepatic and neuromuscular forms of glycogen storage disease type IV caused by mutations in the same glycogen-branching enzyme gene. J Clin Invest 97: 941–948PubMedCrossRefGoogle Scholar
  55. 55.
    Servidei S, Riepe RE, Langston C et al. (1987) Severe cardio- 76. pathy in branching enzyme deficiency. J Pediatr 111: 51–56PubMedCrossRefGoogle Scholar
  56. 56.
    Selby R, Starzl TE, Yunis E et al. (1993) Liver transplantation for type I and type IV glycogen storage disease. Eur J Pediatr 77. 152: S71 - S76CrossRefGoogle Scholar
  57. 57.
    Starzl TE, Demetris AJ, Trucoo M et al. (1993) Chimerism after liver transplantation for type IV glycogen storage disease and type I Gaucher disease. N Engl J Med 328: 745–749 78.Google Scholar
  58. 58.
    Maire I, Baussan C, Moatti N, Mathieu M, Lemonnier A (1991) Biochemical diagnosis of hepatic glycogen storage diseases: 20 years French experience. Clin Biochem 24: 169–178.PubMedCrossRefGoogle Scholar
  59. 59.
    Madiom M, Besley GTN, Cohen PTW, Marrian VJ (1989) Phosphorylase b kinase deficiency in a boy with glycogenosis affecting both liver and muscle. Eur J Pediatr 14 (9): 52–53Google Scholar
  60. 60.
    Kagalwalla AF, Yasmeen A, Sulaiman Al Ajaji et al. (1995) Phosphorylase b kinase deficiency glycogenosis with cirrhosis of the liver. J Pediatr 127: 602–605PubMedCrossRefGoogle Scholar
  61. 61.
    Sanjad SA, Kaddoura RE, Nazir HM et al. (1993) Fanconi’s syndrome with hepatorenal glycogenosis associated with phosphorylase b kinase deficiency. Am J Dis Child 147: 957–959PubMedGoogle Scholar
  62. 62.
    Willems PJ, Gerver WJM, Berger R, Fernandes J (1990) The natural history of liver glycogenosis due to phosphorylase kinase deficiency: a longitudinal study of 41 patients. Eur J Pediatr 149: 268–271PubMedCrossRefGoogle Scholar
  63. 63.
    Hendrickx J, Dams E, Couche P et al. (1996a) X-linked liver glycogenosis type II (XLG II) is caused by mutations in PHKA2, the gene encoding the liver a subunit of phosphorylase kinase. Hum Mol Genet 5: 649–652PubMedCrossRefGoogle Scholar
  64. 64.
    Nakai A, Shigematsu Y, Takano T et al. (1994) Uncooked 84. starch treatment for hepatic phosphorylase kinase deficiency. Eur J Pediatr 153: 581–583PubMedCrossRefGoogle Scholar
  65. 65.
    Smit GPA, Fernandes J, Leonard JV et al. (1990) The longterm outcome of patients with glycogen storage diseases. 85. J Inherit Metab Dis 13: 411–418PubMedCrossRefGoogle Scholar
  66. 66.
    Hendrickx J, Willems PJ (1996b) Genetic deficiencies of the glycogen phosphorylase system. Hum Genet 97: 551–556Google Scholar
  67. 67.
    Burwinkel B, Bakker HD, Herschkovitz E et al. (1998) Mutations in the liver glycogen phosphorylase gene (PYGL) underlying glycogenosis type VI ( Hers disease ). Am J Hum Genet 62: 785–791Google Scholar
  68. 68.
    Van de Berg IET, van Beurden EACM, Malingre HEM et al. (1995) X-linked liver phosphorylase deficiency associated with mutations in the human liver phosphorylase kinase a subunit. Am J Hum Genet 56: 381–387 88.Google Scholar
  69. 69.
    Burwinkel B, Maichelle AJ, Aagenaes O et al. (1997) Autosomal glycogenosis of liver and muscle due to phosphorylase kinase deficiency is caused by mutations in the 89. phosphorylase kinase ß subunit ( PHKB ). Hum Mol Genet 6: 1109–1115Google Scholar
  70. 70.
    Servidei S, DiMauro S (1989) Disorders of glycogen metabolism of muscle. Neurol Clin 7: 159–178PubMedGoogle Scholar
  71. 71.
    Abarbanel JM, Bashan N, Potashnik R et al. (1986) Adult 91. muscle phosphorylase “b” kinase deficiency. Neurology 86: 560–562CrossRefGoogle Scholar
  72. 72.
    Servidei S, Metlay LA, Chodosh J, Di Mauro S (1988) Fatal infantile cardiopathy caused by phosphorylase b kinase 92. deficiency. J Pediatr 113: 82–85PubMedCrossRefGoogle Scholar
  73. 73.
    Fox IH, Palella TD, Kelley WN (1987) Hyperuricemia: a marker for cell energy crisis. N Engl J Med 317: 111–112PubMedCrossRefGoogle Scholar
  74. 74.
    Mineo I, Kono N, Hara N et al. (1987) Myogenic hyperuricemia. A common pathophysiologic feature of glyco 93. genosis types III, V and VII. N Engl J Med 317: 75–80PubMedCrossRefGoogle Scholar
  75. 75.
    Slonim AE, Goans PJ (1985) Myopathy in Mc Ardle’s syndrome. Improvement with a high-protein diet. N Engl J Med 312: 355–359PubMedCrossRefGoogle Scholar
  76. 76.
    Haller RG, Lewis SF (1991) Glucose-induced exertional fatigue in muscle phosphofructokinase deficiency. N Engl J Med 324: 364–369PubMedCrossRefGoogle Scholar
  77. 77.
    Yang BZ, Ding JH, Enghild JJ, Bao Y, Chen YT (1992) Molecular cloning and nucleotide sequence of cDNA encoding human muscle glycogen debranching enzyme. J Biol Chem 267: 9294–9299PubMedGoogle Scholar
  78. 78.
    El-Schahawi M, Tsujino S, Shanske S, di Mauro S (1996) Diagnosis of Mc Ardle’s disease by molecular genetic analysis of blood. Neurology 47: 579–580PubMedCrossRefGoogle Scholar
  79. 79.
    Vosgerd M, Kubisch C, Burwinkel B et al. (1998) Mutation analysis in myophosphorylase deficiency ( Mc Ardle’ disease ). Ann Neurol 43: 326–331CrossRefGoogle Scholar
  80. 80.
    Wilkinson DA, Tonin P, Shanske S et al. (1994) Clinical and biochemical features of to adult patients with muscle phosphorylase kinase deficiency. Neurol 44: 461–466CrossRefGoogle Scholar
  81. 81.
    Wehner M, Clemens PR, Engel AG, Kilimann (1994) Human muscle glycogenosis due to phosphorylase kinase deficiency associated with a nonsense mutation in the muscle isoform of the a subunit. Hum Mol Genet 3: 1983–1987PubMedCrossRefGoogle Scholar
  82. 82.
    Sugie H, Kobayashi J, Sugie Y et al. (1988) Infantile muscle glycogen storage disease: phosphoglucomutase deficiency with decreased muscle and serum carnitine levels. Neurology 38: 602–605PubMedCrossRefGoogle Scholar
  83. 83.
    Whitehouse DB, Putt W, Lovegrove JU et al. (1992) Phosphoglucomutase s: complete human and rabbit mRNA sequencies and direct mapping of this highly polymorphic marker on human chromosome 1. Proc Nail Acad Sci USA 89: 411–415CrossRefGoogle Scholar
  84. 84.
    Vissing J, Galbo H, Haller RG (1996) Paradoxically enhanced glucose production during exercise in humans with blocked glycolysis caused by muscle phosphofructokinase deficiency. Neurology 47: 766–771PubMedCrossRefGoogle Scholar
  85. 85.
    Servidei S, Bonilla E, Diedrich RG et al. (1986) Fatal infantile form of muscle phosphofructokinase deficiency. Neurology 36: 1465–1470PubMedCrossRefGoogle Scholar
  86. 86.
    Howard TD, Akots G, Bowden DW (1996) Physical and genetic mapping of the muscle phosphofructokinase gene (PFKM): reassignment to human chromosome 12q. Genomics 34: 122–127PubMedCrossRefGoogle Scholar
  87. 87.
    Tonin P, Shanske S, Miranda AF et al. (1993) Phosphoglycerate kinase deficiency: biochemical and molecular genetic studies in a new myopathic variant. ( PGK Alberta ). Neurology 43: 387–391PubMedCrossRefGoogle Scholar
  88. 88.
    Tsujino S, Shanske S, Sakoda S et al. (1993) The molecular genetic basis of muscle phosphoglycerate mutase ( PGAM) deficiency. Am J Hum Genet 52: 472–477PubMedGoogle Scholar
  89. 89.
    Kanno T, Sudo K, Takuchi I et al. (1980) Hereditary deficency of lactate dehydrogenase M-subunit. Clin Chim Acta 108: 267PubMedCrossRefGoogle Scholar
  90. 90.
    Gitzelmann R, Spycher MA, Fiel G et al. (1996) Liver glycogen synthase deficiency: a rarely diagnosed entity. Eur J Pediatr 155: 561–567PubMedCrossRefGoogle Scholar
  91. 91.
    Byrne BM, Killmer MD, Turner RC, Aynsley-Green A (1995) Glucose homoiostasis in adulthood and in pregnancy in a patient with hepatic glycogen synthase deficiency. Br J Obstet Gynaecol 102: 931–933PubMedCrossRefGoogle Scholar
  92. 92.
    Santer R, Schneppenheim R, Dombrowski A et al. (1997) Mutations in GLUT 2, the gene for the liver-type glucose transporter in patients with Fanconi-Bickel syndrome. Nature Genet 17: 324–326 (published erratum in Nature Genet 18:298, 1998)PubMedCrossRefGoogle Scholar
  93. 93.
    Santer R, Schneppenheim R, Suter D, Schaub J, Steinmann B (1998) Fanconi-Bickel syndrome - the original patient and his natural history, historical steps leading to the primary defect, and a review of the literature. Review. Eur J Pediatr 157: 783–797Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2000

Authors and Affiliations

  • J. Fernandes
  • G. P. A. Smit

There are no affiliations available

Personalised recommendations